Published in Bone on September 01, 1996
Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts. J Biol Chem (2005) 1.96
Ubiquitin ligase Smurf1 mediates tumor necrosis factor-induced systemic bone loss by promoting proteasomal degradation of bone morphogenetic signaling proteins. J Biol Chem (2008) 1.41
Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance. Diabetes (2012) 1.38
Pharmacologic manipulation of sphingosine kinase in retinal endothelial cells: implications for angiogenic ocular diseases. Invest Ophthalmol Vis Sci (2006) 0.99
Msx2 mediates the inhibitory action of TNF-alpha on osteoblast differentiation. Exp Mol Med (2010) 0.93
Loss of NF-kappaB activity during cerebral ischemia and TNF cytotoxicity. Mol Med (1999) 0.91
Sirt1 overexpression protects murine osteoblasts against TNF-α-induced injury in vitro by suppressing the NF-κB signaling pathway. Acta Pharmacol Sin (2012) 0.84
Phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations. Int J Mol Sci (2013) 0.84
A possible involvement of ion transporter in tumor necrosis factor alpha and cycloheximide-induced apoptosis of endothelial cells. Mediators Inflamm (1999) 0.79
Identification of C-terminal Hsp70-interacting protein as a mediator of tumour necrosis factor action in osteoblast differentiation by targeting osterix for degradation. J Cell Mol Med (2015) 0.75
Simvastatin attenuates TNF-alpha-induced growth inhibition and apoptosis in murine osteoblastic MC3T3-E1 cells. Inflamm Res (2010) 0.75
Qualitative comparison of carbon dioxide-induced change in cerebral near-infrared spectroscopy versus jugular venous oxygen saturation in adults with acute brain disease. Crit Care Med (1995) 2.74
Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial. J Thromb Haemost (2006) 2.40
Chronic inflammatory arthropathy associated with HTLV-I. Lancet (1989) 2.28
Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells. Int Immunol (1991) 2.27
Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet (1996) 2.17
Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome. Muscle Nerve (1998) 2.06
Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta. J Cell Biol (1985) 1.92
Structure of the planarian central nervous system (CNS) revealed by neuronal cell markers. Zoolog Sci (1998) 1.68
Ocular manifestations in patients infected with human T-lymphotropic virus type I. Jpn J Ophthalmol (1989) 1.63
Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation. EMBO J (1987) 1.60
Recurrent histiocytic necrotizing lymphadenitis (Kikuchi's disease) in an human T lymphotropic virus type I carrier. Intern Med (1996) 1.60
Prolonged paraplegia after iohexol myelography. Lancet (1991) 1.58
Increased circulating vascular endothelial growth factor is correlated with disease activity in polyarticular juvenile rheumatoid arthritis. J Rheumatol (1999) 1.57
Marked increase in plasma interleukin-6 in burn patients. J Lab Clin Med (1992) 1.55
Isolation and characterization of thrombomodulin from human placenta. J Biol Chem (1984) 1.50
Hepatic artery pseudoaneurysms in a patient treated for miliary tuberculosis. Intern Med (2000) 1.48
Revisiting the safety of living liver donors by reassessing 441 donor hepatectomies: is a larger hepatectomy complication-prone? Am J Transplant (2014) 1.44
Analysis of cerebellar motor disorders by visually-guided elbow tracking movement. 2. Contribution of the visual cues on slow ramp pursuit. Brain (1987) 1.43
High-mobility group box 1 protein promotes development of microvascular thrombosis in rats. J Thromb Haemost (2007) 1.42
Impact of human T cell leukemia virus type 1 in living donor liver transplantation. Am J Transplant (2012) 1.39
Donepezil for mild and moderate Alzheimer's disease. Cochrane Database Syst Rev (2000) 1.38
Hgs (Hrs), a FYVE domain protein, is involved in Smad signaling through cooperation with SARA. Mol Cell Biol (2000) 1.37
Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg (2013) 1.37
Thrombomodulin: protectorate God of the vasculature in thrombosis and inflammation. J Thromb Haemost (2011) 1.32
Adenosine-sensitive atrial reentrant tachycardia originating from the atrioventricular nodal transitional area. J Cardiovasc Electrophysiol (1997) 1.30
Highly concentrated vascular endothelial growth factor in platelets in Crow-Fukase syndrome. Muscle Nerve (2000) 1.26
Safety and risk of using pediatric donor livers in adult liver transplantation. Liver Transpl (2001) 1.17
Phosphoinositide-3 kinase-PKB/Akt pathway activation is involved in fibroblast Rat-1 transformation by human T-cell leukemia virus type I tax. Oncogene (2001) 1.17
Analysis of cerebellar motor disorders by visually guided elbow tracking movement. Brain (1984) 1.16
Polyarthritis in human T lymphotropic virus type I-associated myelopathy. Arthritis Rheum (1989) 1.15
Leptin promotes aggregation of human platelets via the long form of its receptor. Diabetes (1999) 1.15
The last three consecutive epidermal growth factor-like structures of human thrombomodulin comprise the minimum functional domain for protein C-activating cofactor activity and anticoagulant activity. J Biol Chem (1989) 1.13
The turnover of thrombin-thrombomodulin complex in cultured human umbilical vein endothelial cells and A549 lung cancer cells. Endocytosis and degradation of thrombin. J Biol Chem (1985) 1.12
Upregulation of toll-like receptor 2 gene expression in macrophage response to peptidoglycan and high concentration of lipopolysaccharide is involved in NF-kappa b activation. Infect Immun (2001) 1.12
Mechanisms of photoreceptor cell death in cancer-associated retinopathy. Invest Ophthalmol Vis Sci (2001) 1.11
Arthritis in patients infected with human T lymphotropic virus type I. Clinical and immunopathologic features. Arthritis Rheum (1991) 1.11
Fluctuation of HTLV-I proviral DNA in peripheral blood mononuclear cells of HTLV-I-associated myelopathy. J Neuroimmunol (1993) 1.11
Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells. J Virol (1992) 1.10
Frameshift mutation in the collagen VI gene causes Ullrich's disease. Ann Neurol (2001) 1.09
Identification of nucleolin as a binding protein for midkine (MK) and heparin-binding growth associated molecule (HB-GAM). J Biochem (1994) 1.09
Enhanced expression of type I receptors for bone morphogenetic proteins during bone formation. J Bone Miner Res (1995) 1.08
Detection of human T cell lymphotropic virus type I proviral DNA and its gene expression in synovial cells in chronic inflammatory arthropathy. J Clin Invest (1991) 1.07
Human thrombomodulin is not an efficient inhibitor of the procoagulant activity of thrombin. J Clin Invest (1985) 1.07
Thrombomodulin as a marker for vascular tumors. Comparative study with factor VIII and Ulex europaeus I lectin. Am J Clin Pathol (1987) 1.07
Arthritis in a human T lymphotropic virus type I (HTLV-I) carrier. Ann Rheum Dis (1990) 1.05
Sequential MR studies of cervical cord injury: correlation with neurological damage and clinical outcome. Spinal Cord (1999) 1.05
Coagulation factor Va binds to human umbilical vein endothelial cells and accelerates protein C activation. J Clin Invest (1984) 1.05
Cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo. Invest Ophthalmol Vis Sci (1999) 1.04
Expression of vascular endothelial growth factor in sera and lymph nodes of the plasma cell type of Castleman's disease. Br J Haematol (1999) 1.03
Choto-san in the treatment of vascular dementia: a double-blind, placebo-controlled study. Phytomedicine (1997) 1.02
Hereditary deficiency of the third component of complement in two sisters with systemic lupus erythematosus-like symptoms. Arthritis Rheum (1981) 1.01
Expression of type XII collagen and hemidesmosome-associated proteins in keratoconus corneas. Curr Eye Res (2001) 1.01
Molecular typing of the methicillin resistance determinant (mec) of clinical strains of Staphylococcus based on mec hypervariable region length polymorphisms. J Lab Clin Med (1995) 1.01
A novel automated microchip flow-chamber system to quantitatively evaluate thrombus formation and antithrombotic agents under blood flow conditions. J Thromb Haemost (2011) 1.00
An autoaggressive process against bystander tissues in HTLV-I-infected individuals: a possible pathomechanism of HAM/TSP. Med Hypotheses (1993) 1.00
Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node. Leuk Lymphoma (2000) 1.00
Neutrophil elastase inhibitor improves postoperative clinical courses after thoracic esophagectomy. Dis Esophagus (2007) 0.99
Sequential MRI studies in patients with cervical cord injury but without bony injury. Paraplegia (1995) 0.99
Amelioration of liver injury by ischaemic preconditioning. Br J Surg (1998) 0.99
Polymyxin B binds to anandamide and inhibits its cytotoxic effect. FEBS Lett (2000) 0.97
A method of mixed dentition analysis in the mandible. ASDC J Dent Child (1987) 0.97
Overgrowth of human synovial cells driven by the human T cell leukemia virus type I tax gene. J Clin Invest (1993) 0.96
Traumatic occlusion of the anterior cerebral artery--case report. Neurol Med Chir (Tokyo) (1995) 0.96
Clinical and microangiographic studies on rupture of the E.P.L. tendon after distal radial fractures. J Hand Surg Br (1990) 0.96
Anandamide induces cell death independently of cannabinoid receptors or vanilloid receptor 1: possible involvement of lipid rafts. Cell Mol Life Sci (2003) 0.95
Thrombin receptor-mediated synovial proliferation in patients with rheumatoid arthritis. Clin Immunol Immunopathol (1995) 0.95
Vascular endothelial growth factor (VEGF) is one of the cytokines causative and predictive of hepatic veno-occlusive disease (VOD) in stem cell transplantation. Bone Marrow Transplant (2001) 0.94
Activated T lymphocytes in cerebrospinal fluid of patients with HTLV-I-associated myelopathy (HAM/TSP). J Neuroimmunol (1989) 0.94
Biosynthesis of coagulation Factor V by a human hepatocellular carcinoma cell line. J Clin Invest (1984) 0.94
Anandamide induces apoptosis of PC-12 cells: involvement of superoxide and caspase-3. FEBS Lett (2000) 0.94
Deranged blood coagulation equilibrium as a factor of massive liver necrosis following endotoxin administration in partially hepatectomized rats. Hepatology (1999) 0.93
Measurement of maxillary sinus volume using computerized tomographic images. Int J Oral Maxillofac Implants (1999) 0.93
Is graft size a major risk factor in living-donor adult liver transplantation? Transpl Int (2004) 0.93
Mitochondrial encephalomyopathy: fluctuating symptoms and CT. Neurology (1984) 0.92
Nitric oxide induces apoptosis via Ca2+-dependent processes in the pancreatic beta-cell line MIN6. Cell Struct Funct (1999) 0.92
Induction of apoptosis in murine clonal osteoblasts expressed by human T-cell leukemia virus type I tax by NF-kappa B and TNF-alpha. J Bone Miner Res (1996) 0.92
Thrombin receptor mediated signals induce expressions of interleukin 6 and granulocyte colony stimulating factor via NF-kappa B activation in synovial fibroblasts. Ann Rheum Dis (1999) 0.91
Tumor necrosis factor-alpha stimulates gingival epithelial cells to release high mobility-group box 1. J Periodontal Res (2007) 0.91
Antithrombotic effect of recombinant human thrombomodulin on thrombin-induced thromboembolism in mice. Blood (1990) 0.91
Atrophy of the cerebellum and brainstem in dentatorubral pallidoluysian atrophy. Influence of CAG repeat size on MRI findings. Neurology (1997) 0.91
Syndrome of plasma cell dyscrasia, polyneuropathy, and endocrine disturbances. Report of a case. Ann Intern Med (1974) 0.90
Cerebral circulation and metabolism in patients with septic encephalopathy. Am J Emerg Med (1991) 0.90
Involvement of NF-kappa B activation in thrombin-induced human vascular smooth muscle cell proliferation. Biochem Biophys Res Commun (1994) 0.90
Diabetogenic action of streptozotocin: essential role of membrane permeability. Acta Endocrinol (Copenh) (1987) 0.89
The antithrombotic effects of recombinant human soluble thrombomodulin (rhsTM) on tissue factor-induced disseminated intravascular coagulation in crab-eating monkeys (Macaca fascicularis). Blood Coagul Fibrinolysis (1997) 0.89
In vitro modulation of lymphocyte proliferation by prednisolone and interferon-alpha in patients with HTLV-I-associated myelopathy (HAM). J Neuroimmunol (1989) 0.89
The role of vascular endothelial growth factor in human dental pulp cells: induction of chemotaxis, proliferation, and differentiation and activation of the AP-1-dependent signaling pathway. J Dent Res (2000) 0.89
Retracted Increased serum high mobility group box-1 level in Churg-Strauss syndrome. Clin Exp Immunol (2007) 0.89
Nerve distribution to the human knee joint: anatomical and immunohistochemical study. Int Orthop (2000) 0.89